OraSure Technologies Inc
$ 3.21
-0.93%
16 Apr - close price
- Market Cap 221,895,000 USD
- Current Price $ 3.21
- High / Low $ 3.24 / 3.17
- Stock P/E N/A
- Book Value 4.84
- EPS -0.94
- Next Earning Report 2026-05-06
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.10 %
- ROE -0.18 %
- 52 Week High 3.82
- 52 Week Low 2.08
About
OraSure Technologies, Inc. develops, manufactures, markets, and sells oral fluid diagnostic products and sample collection devices in the United States, Europe, and internationally. The company is headquartered in Bethlehem, Pennsylvania.
Analyst Target Price
$5.00
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-25 | 2025-11-05 | 2025-08-06 | 2025-05-06 | 2025-02-25 | 2024-11-06 | 2024-08-06 | 2024-05-08 | 2024-02-27 | 2023-11-07 | 2023-08-03 | 2023-05-10 |
| Reported EPS | -0.19 | -0.13 | -0.26 | -0.18 | -0.06 | -0.06 | -0.01 | -0.05 | 0.27 | 0.15 | 0.09 | 0.37 |
| Estimated EPS | -0.19 | -0.19 | -0.17 | -0.1223 | -0.0107 | -0.08 | -0.03 | 0.01 | 0.09 | 0.04 | -0.08 | 0.14 |
| Surprise | 0 | 0.06 | -0.09 | -0.0577 | -0.0493 | 0.02 | 0.02 | -0.06 | 0.18 | 0.11 | 0.17 | 0.23 |
| Surprise Percentage | 0% | 31.5789% | -52.9412% | -47.1791% | -460.7477% | 25% | 66.6667% | -600% | 200% | 275% | 212.5% | 164.2857% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-06 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | -0.2 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: OSUR
2026-04-17 00:39:01
OraSure Technologies, Inc. announced the appointment of John D. Bertrand to its Board of Directors as an independent director, effective immediately. Mr. Bertrand brings over a decade of experience in AI-enabled diagnostics and healthcare technology. Concurrently, OraSure entered a Cooperation Agreement with Altai Capital Management and will seek shareholder approval to declassify its Board at the 2026 Annual Meeting, reinforcing its commitment to strong governance and shareholder engagement.
2026-04-17 00:39:01
OraSure Technologies (NASDAQ: OSUR) has appointed John D. Bertrand as an independent director to its Board. Concurrently, the company announced its intention to seek shareholder approval at the 2026 Annual Meeting to declassify its Board. These actions follow a Cooperation Agreement with Altai Capital Management, L.P., which will withdraw its director nominations and engage in regular discussions with OraSure's management.
2026-04-13 17:09:01
OraSure Technologies (NASDAQ:OSUR) experienced a significant surge in options trading, with traders acquiring over 7,000 call options, marking a 2,394% increase in daily volume. This heightened activity suggests increased investor interest and potential future volatility for the medical device company's stock. Investors are closely watching how this speculation might impact OraSure's share price in the coming days and weeks.
2026-04-13 16:09:01
OraSure Technologies (NASDAQ:OSUR) experienced an unusually high volume of call options traded on Monday, with 7,008 calls indicating significant short-term interest. Despite this, analysts maintain a "Reduce" rating with a $3.00 target price, while the stock currently trades around $3.02. Key insiders, including the CEO and CFO, recently increased their stakes by purchasing shares at an average price of $2.93.
2026-04-08 22:10:02
Neil Gagnon has reported a 5.4% beneficial ownership stake in Orasure Technologies Inc. (NASDAQ: OSUR) through a Schedule 13G filing. This ownership comprises 3,754,846 shares, including those managed by Gagnon Securities LLC and Gagnon Advisors, LLC. The filing clarifies the voting and dispositive powers held by Neil Gagnon and the associated advisory entities, disclaiming beneficial ownership for securities in client and managed accounts.
2026-04-08 07:40:57
OraSure Technologies (NASDAQ:OSUR) stock recently crossed above its 200-day moving average, trading at $3.06 compared to the $2.77 average. Despite this, the company faces a "Reduce" consensus rating from analysts, a missed EPS in its last quarterly earnings, and negative profit margins. Notably, the CEO and CFO both recently purchased significant shares, indicating insider confidence despite the otherwise weak fundamental outlook.
